You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 5, August 4, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •World Health
 •Bacterial Infections
 •Tuberculosis/ Other Mycobacterium
 •Alert me on articles by topic

A Community-Based Tuberculosis Program in Cambodia

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Cambodia has one of the highest global burdens of tuberculosis (TB).1 In 1994, the Cambodian Health Committee (CHC), a nongovernmental organization, developed a community-based approach to the treatment of TB using microfinance and food supplementation in Svay Rieng, one of Cambodia's poorest provinces.

Methods

The program comprised 2 components: a health center–based component (hospital/health care center [HHC]) and a home-based component (Home Directly Observed Therapy Short Course [Home DOTS]). The mean annual target population was 149 577 for the HHC component and 11 557 for the Home DOTS component. Between 1994 and 2001, 2780 patients with TB were treated in the HHC protocol involving DOTS (with 2 months of forced hospitalization during the period 1994-1999, per the national protocol), followed by 6 months of outpatient therapy with monthly drug pick-up at the HHC. After 1999, daily health center visits were offered as an alternative to hospitalization during the intensive phase. . . . [Full Text of this Article]

Sok Thim; Sun Sath; Meas Sina
Cambodian Health Committee
Phnom Penh

Eunice Y. Tsai, MD; Julio C. Delgado, MD; Adrienne E. Shapiro, MSc
CBR Institute for Biomedical Research
Harvard Medical School
Boston, Mass

Clifton E. Barry III, PhD
TB Research Section
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Rockville, Md

Philippe Glaziou, MD
Institut Pasteur du Cambodge
Phnom Penh

Anne E. Goldfeld, MD
goldfeld@cbr.med.harvard.edu
Cambodian Health Committee
Phnom Penh
CBR Institute for Biomedical Research
Harvard Medical School







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.